Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness and tolerability of bimatoprost vs tafluprost eye drops in glaucoma and ocular hypertension
2014-000404-10Phase 4Active
- Sponsor
- Hospital Clínico San Carlos
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bimatoprost and tafluprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoint: Intraocular pressure at 9:00, 12:00, and 15:00. Started Dec 2014; status: active.
02
Drugs
bimatoprosttafluprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2014-000404-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000404-10.